Skip to content
Search

Latest Stories

NHS unveils new policy to combat sexual misconduct in the workplace

NHS unveils new policy to combat sexual misconduct in the workplace

An anonymous reporting option allows NHS staff to report incidents of sexual misconduct without disclosing their identity  

As part of major plans to improve staff safety, the National Health Service (NHS) has unveiled a new policy aimed at tackling sexual misconduct within the health service.

The policy, which is now available for immediate adoption by local hospitals, outlines how those working in the health service should recognise, report and act on sexual misconduct in the workplace.


A key component of the support package is the introduction of an anonymous reporting option, allowing employees to report sexual abuse without having to disclose their names or personal details.

The framework also provides guidance for conducting investigations, which includes forming a specialist review group with access to subject matter experts and independent investigators.

NHS chief executive Amanda Pritchard emphasised the importance of creating a supportive environment for staff, stating, “For anyone who has experienced sexual abuse or misconduct at work, it is an extremely distressing and isolating experience, and so we must do everything in our power to ensure our staff feel able to speak up, and have absolute confidence that they will be given the support they need when they do.”

Pritchard hopes that the new national policy will help NHS colleagues take the right steps in recognising, reporting and acting on sexual misconduct at work.

“By introducing the option of anonymous reporting, we are making it easier for staff to come forward to report issues – it marks our serious commitment to stamping out this horrendous behaviour,” she added.

She firmly stated that “there is absolutely no place for sexual misconduct or abuse of any kind within the NHS.”

“We know that women are more likely to be affected – this is unacceptable, and we must not tolerate it.”

However, Pritchard acknowledged that this is just one of the first steps to ending harmful sexual behaviour in the NHS, and that more action is needed.

Pritchard encourages leaders across the health service to adopt these measures to ensure that staff feel safe and supported.

The NHS noted that the policy has been developed in partnership with staff who have lived experience, trade unions, colleagues in the voluntary, community and social enterprise sector, academics experts, and system leaders.

It covers various forms of sexual misconduct connected to work or the workplace such as:

  • sexual comments or jokes
  • unwanted touching or kissing
  • showing sexual pictures
  • staring at someone in a sexual way
  • asking personal questions about someone’s sex life
  • sexual assault or rape

According to the 2023/24 NHS staff survey for England, one in eight workers—approximately 58,000—reported experiencing unwanted sexual behaviour in the past year, while one in 26 reported facing similar harassment from a colleague.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less